Evaluation of Synthetic FK506 Analogues as Ligands for the FK506-Binding Proteins 51 and 52

被引:54
作者
Gopalakrishnan, Ranganath [1 ]
Kozany, Christian [1 ]
Gaali, Steffen [1 ]
Kress, Christoph [1 ]
Hoogeland, Bastiaan [1 ]
Bracher, Andreas [2 ]
Hausch, Felix [1 ]
机构
[1] Max Planck Inst Psychiat, D-80804 Munich, Germany
[2] Max Planck Inst Biochem, D-82152 Martinsried, Germany
关键词
ALPHA-HYDROXYMETHYLATION; GLUCOCORTICOID-RECEPTOR; BINDING-PROTEIN; FKBP12; LIGANDS; DOMAIN; AFFINITY; COMPLEX; DESIGN;
D O I
10.1021/jm201746x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The FK506-binding proteins (FKBP) 51 and 52 are cochaperones that modulate the signal transduction of steroid hormone receptors. Both proteins have been implicated in prostate cancer. Furthermore, single nucleotide polymorphisms in the gene encoding FKBP51 have been associated with a variety of psychiatric disorders. Rapamycin and FK506 are two macrocyclic natural products that bind to these proteins indiscriminately but with nanomolar affinity. We here report the cocrystal structure of FKBP51 with a simplified alpha-ketoamide analogue derived from FK506 and the first structure-activity relationship analysis for FKBP51 and FKBP52 based on this compound. In particular, the tert-pentyl group of this ligand was systematically replaced by a cyclohexyl ring system, which more closely resembles the pyranose ring in the high-affinity ligands rapamycin and FK506. The interaction with FKBPs was found to be surprisingly tolerant to the stereochemistry of the attached cyclohexyl substituents. The molecular basis for this tolerance was elucidated by X-ray cocrystallography.
引用
收藏
页码:4114 / 4122
页数:9
相关论文
共 49 条
[1]  
Armistead M.D., 1998, Biologically active acylated amino acid derivatives, Patent No. [US6187784, 6187784]
[2]   Neuropsin cleaves EphB2 in the amygdala to control anxiety [J].
Attwood, Benjamin K. ;
Bourgognon, Julie-Myrtille ;
Patel, Satyam ;
Mucha, Mariusz ;
Schiavon, Emanuele ;
Skrzypiec, Anna E. ;
Young, Kenneth W. ;
Shiosaka, Sadao ;
Korostynski, Michal ;
Piechota, Marcin ;
Przewlocki, Ryszard ;
Pawlak, Robert .
NATURE, 2011, 473 (7347) :372-U553
[3]   FKBP immunophilin patents for neurological disorders [J].
Babine, RE ;
Villafranca, JE ;
Gold, BG .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (05) :555-573
[4]  
Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI [10.1016/j.psyneuen.2008.08.018, 10.1016/j.psyneuen.2009.05.021]
[5]   A role for Schwann cells in the neuroregenerative effects of a non-immunosuppressive FK506 derivative, JNJ460 [J].
Birge, RB ;
Wadsworth, S ;
Akakura, R ;
Abeysinghe, H ;
Kanojia, R ;
MacIelag, M ;
Desbarats, J ;
Escalante, M ;
Singh, K ;
Sundarababu, S ;
Parris, K ;
Childs, G ;
August, A ;
Siekierka, J ;
Weinstein, DE .
NEUROSCIENCE, 2004, 124 (02) :351-366
[6]   SYNTHETIC FKBP12 LIGANDS - DESIGN AND SYNTHESIS OF PYRANOSE REPLACEMENTS [J].
BIRKENSHAW, TN ;
CAFFREY, MV ;
CLADINGBOEL, DE ;
COOPER, ME ;
DONALD, DK ;
FURBER, M ;
HARDERN, DN ;
HARRISON, RP ;
MARRIOTT, DP ;
PERRY, MWD ;
STOCKS, MJ ;
TEAGUE, SJ ;
WITHNALL, WJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (21) :2501-2506
[7]   Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90 [J].
Bracher, Andreas ;
Kozany, Christian ;
Thost, Ann-Katrin ;
Hausch, Felix .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2011, 67 :549-559
[8]  
Bull D.J., 1999, Heterocyclic compounds as inhibitors of rotamase enzymes, Patent No. [WO/1999/045006, 1999045006]
[9]   SYNTHESIS AND EVALUATION OF DUAL DOMAIN MACROCYCLIC FKBP12 LIGANDS [J].
CAFFREY, MV ;
CLADINGBOEL, DE ;
COOPER, ME ;
DONALD, DK ;
FURBER, M ;
HARDERN, DN ;
HARRISON, RP ;
STOCKS, MJ ;
TEAGUE, SJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (21) :2507-2510
[10]   L-Threonine-catalysed asymmetric α-hydroxymethylation of cyclohexanone: application to the synthesis of pharmaceutical compounds and natural products [J].
Chen, Anqi ;
Xu, Jin ;
Chiang, Winnie ;
Chai, Christina L. L. .
TETRAHEDRON, 2010, 66 (07) :1489-1495